MasterCard Inc vs Philip Morris International Inc. — how do they compare? MasterCard Inc trades at $546.79 (market cap $483.71B), while Philip Morris International Inc. trades at $192.33 (market cap $300.37B). The key difference: MasterCard Inc is the larger of the two by market cap, and Philip Morris International Inc. pays the higher dividend (3.05%). Which is the better fit depends on your goals.
| MA | PM | |
|---|---|---|
Market Cap | $483.71B | $300.37B |
Volume | 4,635,698 | — |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $598.96 | $192.98 |
52-Week Low | $471.55 | $144.33 |
Enterprise Value | $494.45B | $346.86B |
Dividend Yield | 0.64% | 3.05% |
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $543.6, down 1.44% on the day, with strong technical support near $540 and bullish moving average signals. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding expectations of $4.41. Revenue grew to $32.79B in 2025, and net income margin remains high at 45.88%. Analysts maintain a strong buy consensus with a $634.27 price target, reflecting 16.7% upside potential.
Outlook remains positive driven by payment volume growth and AI initiatives, but risks include competitive disruption from stablecoins and high valuation multiples. Institutional ownership trends show continued accumulation, supporting bullish sentiment. The stock's current price is within 5% of recent highs, indicating potential for consolidation before further gains.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →